Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Exercise & healthspan
Research brief

12-month structured exercise and epicardial fat in older adults: a randomized trial

In community-dwelling adults aged 60 and older, a 12-month structured exercise program was associated with a greater reduction in epicardial adipose volume than health education alone, and with lower serum M-CSF; more weekly sessions went with larger reductions. [1]

Automatic summary · not editorially reviewed

The key findings

  1. 156 community-dwelling adults aged 60 or older were evenly allocated to structured exercise or a control group receiving health education only. [1]

  2. The absolute change in epicardial adipose volume differed significantly between groups: exercise versus control -15.15 mL (95% CI -22.61 to -7.69). [1]

  3. Each additional weekly exercise session was associated with a 3.156 mL greater reduction in epicardial adipose volume (R = 0.084). [1]

The source at a glance

Study type / format
Single-center pragmatic randomized controlled trial (Zelen design); abstract
Population / context
Community-dwelling adults aged 60 or older; 118 completed the 12-month follow-up.
Summary based on
Study abstract
Original publication
September 16, 2026

Exercise versus education in adults 60 and older

This single-center randomized controlled trial used a Zelen design and enrolled 156 community-dwelling adults aged 60 or older, allocated evenly to a structured exercise group or a control group. The control group received health education only. The exercise group did one supervised session at a center plus at least two home-based sessions per week, with matched intensity and duration. Epicardial adipose volume, body fat measures and circulating pro-inflammatory factors were measured at baseline and after 12 months.

Supporting source [1]

Epicardial fat fell more with exercise; M-CSF lower

Of the randomized participants, 57 in the control group and 61 in the exercise group completed the 12-month follow-up (55 men, 46.6%; mean age 69.17 ± 4.41 years). The absolute change in epicardial adipose volume differed significantly between groups: exercise versus control -15.15 mL (95% CI -22.61 to -7.69). The conclusion reports lower circulating M-CSF levels with the exercise program. Univariate linear regression indicated that each additional weekly exercise session was associated with a 3.156 mL greater reduction in epicardial adipose volume (R = 0.084).

Supporting source [1]

Abstract-only scope of the exercise trial

These results come from the abstract; the full text was not reviewed. The findings are associations from one single-center pragmatic trial, not proof that exercise causes the changes. The session-frequency result rests on a weak correlation (R = 0.084). The abstract does not report adverse events, adherence beyond session counts, or whether the M-CSF difference was statistically significant. The authors describe regular supervised exercise as a non-pharmacological strategy; this is their interpretation, not personal advice.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. Single-center pragmatic trial; findings are associations, not causation. The frequency result relies on a weak correlation (R = 0.084). Adverse events, adherence and statistical significance of the M-CSF difference are not reported in the abstract.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    The control group received health education only
  2. Finding 2 ↑

    STE vs. control: -15.15 mL
  3. Finding 3 ↑

    3.156 mL greater EAV reduction

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…